Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control

The number of diabetic patients has risen dramatically in recent decades, owing mostly to the rising incidence of type 2 diabetes mellitus (T2DM). Several oral antidiabetic medications are used for the treatment of T2DM including, α-glucosidases inhibitors, biguanides, sulfonylureas, meglitinides, G...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Mahmoud E., Yahya, Galal, Popoviciu, Mihaela Simona, Cavalu, Simona, Abd-Eldayem, Marwa A., Saber, Sameh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094124/
https://www.ncbi.nlm.nih.gov/pubmed/37047011
http://dx.doi.org/10.3390/ijms24076039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094124/
https://www.ncbi.nlm.nih.gov/pubmed/37047011
http://dx.doi.org/10.3390/ijms24076039

Ejemplares similares